| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/17/2012 | CA2473986C Indazole compounds useful as protein kinase inhibitors |
| 01/17/2012 | CA2465007C Methods and means for producing proteins with predetermined post-translational modifications |
| 01/17/2012 | CA2385456C 9-(piperazinylalkyl) carbazoles as bax-modulators |
| 01/12/2012 | WO2012006500A2 Monoclonal antibodies against hepatitis c virus core protein |
| 01/12/2012 | WO2012006205A1 Crystalline form of a 3-phenoxymethylpyrrolidine compound |
| 01/12/2012 | WO2012005368A1 Single-strand nucleic acid molecule for controlling gene expression |
| 01/12/2012 | WO2012005227A1 Tetrahydrocarboline derivative |
| 01/12/2012 | WO2012004966A1 Therapeutic agent for fibromyalgia containing etanercept |
| 01/12/2012 | WO2012004875A1 Novel substance separated from orchidaceous plant, and extract, antioxidant, antibacterial agent, anticancer agent and antiinflammatory agent containing same |
| 01/12/2012 | WO2012004743A1 Benzenesulfonamides useful as sodium channel inhibitors |
| 01/12/2012 | WO2012004698A1 Piperidinyl pyrimidine amides as kv7 potassium channel openers |
| 01/12/2012 | WO2012004677A1 Solid state forms of etoricoxib salts |
| 01/12/2012 | WO2012004522A1 Macromolecular complex of bacterial origin and use of said macromolecular complex for preventing and treating inflammatory rheumatism |
| 01/12/2012 | WO2012004390A1 Xanthenedione derivatives for the treatment of pigmentation and skin ageing disorders |
| 01/12/2012 | WO2012004299A1 Tetrahydro-pyrido-pyrimidine derivatives |
| 01/12/2012 | WO2012004287A1 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate (s1p) receptors |
| 01/12/2012 | WO2012003912A1 Bipyridyl derivatives useful for the treatment of kinase - induced diseases |
| 01/12/2012 | WO2012003829A1 Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 01/12/2012 | WO2012003544A1 Protein kinase inhibitors and methods of treatment |
| 01/12/2012 | WO2011118957A3 Composition for treating inflammatory, allergic or asthma diseases, containing paprika extracts |
| 01/12/2012 | WO2011115778A9 Aerosolized dapsone as a therapy for inflammation of the airway and abnormal mucociliary transport |
| 01/12/2012 | WO2011112731A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/12/2012 | WO2011109353A3 Immunosuppressant extracts derived from millettia laurentii or pseudotsuga pinaceae |
| 01/12/2012 | WO2011103413A3 Taxane pro-emulsion formulations and methods making and using the same |
| 01/12/2012 | WO2011099832A3 Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same |
| 01/12/2012 | WO2011087765A3 Methods of producing stabilized solid pharmaceutical compositions containing morphinans |
| 01/12/2012 | WO2011039511A4 Agents, uses and methods |
| 01/12/2012 | US20120010286 Prevention of neutrophil recruitment |
| 01/12/2012 | US20120010284 Controlled release of biologically active compounds from multi-armed oligomers |
| 01/12/2012 | US20120010282 Tautomycetin and Tautomycetin Analog Biosynthesis |
| 01/12/2012 | US20120010265 Crystalline form of a 3-phenoxymethylpyrrolidine compound |
| 01/12/2012 | US20120010263 Acetylene derivatives having mglur 5 antagonistic activity |
| 01/12/2012 | US20120010256 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 01/12/2012 | US20120010231 Dihydroetorphines and Their Preparation |
| 01/12/2012 | US20120010212 Methyl-pyrrolidine ether derivatives |
| 01/12/2012 | US20120010207 Chemical Compounds |
| 01/12/2012 | US20120010203 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 01/12/2012 | US20120010197 Protein kinase inhibitors |
| 01/12/2012 | US20120010191 Pyridone and aza-pyridone compounds and methods of use |
| 01/12/2012 | US20120010190 1-hydroxyimino-3-phenyl-propanes |
| 01/12/2012 | US20120010188 Imidazopyridine Compounds |
| 01/12/2012 | US20120010184 Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Receptor |
| 01/12/2012 | US20120010183 Chemical Compounds |
| 01/12/2012 | US20120010181 Compounds for the treatment of inflammatory disorders |
| 01/12/2012 | US20120010172 Novel urea and thiourea derivatives |
| 01/12/2012 | US20120010168 Unique Dual-Action Therapeutics |
| 01/12/2012 | US20120010159 Combination therapies with cox-2 inhibitors and treprostinil |
| 01/12/2012 | US20120010156 Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1 |
| 01/12/2012 | US20120010136 Use of cd31 peptides in the treatment of thrombotic and autoimmune disorders |
| 01/12/2012 | US20120010126 Recombinant surfactant protein d compositions and methods of use thereof |
| 01/12/2012 | US20120009288 Use of acacia extracts and their compounds on inhibition of xanthine oxidase |
| 01/12/2012 | US20120009253 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds of the lower respiratory tract |
| 01/12/2012 | US20120009243 Liposomes for drug delivery and methods for preparation thereof |
| 01/12/2012 | US20120009226 Highly pure laquinimod or a pharmaceutically acceptable salt thereof |
| 01/12/2012 | US20120009211 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 01/12/2012 | US20120009208 USE OF MEMBRANE ATTACK COMPLEX (MAC) AND IMMUNE COMPLEXES (ICs) TO ACTIVATE T-CELLS AND THE GENERATION OF REGULATORY T CELLS |
| 01/12/2012 | US20120009196 Monoclonal antibodies against hepatitis c virus core protein |
| 01/12/2012 | US20120009195 Antibody neutralizers of human granulocyte macrophage colony stimulating factor |
| 01/12/2012 | US20120009193 Method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same |
| 01/12/2012 | US20120009190 Identification and method for using the pre-ligand assembly domain of the il-17 receptor |
| 01/12/2012 | US20120009188 Optimized fc variants |
| 01/12/2012 | US20120009184 Anti-C5 Alpha Antibodies |
| 01/12/2012 | US20120009183 Method for treatment of pancreatitis |
| 01/12/2012 | US20120009178 Tweak binding antibodies |
| 01/12/2012 | US20120009170 METHOD OF TREATING INFLAMMATORY LUNG DISEASE WITH SUPPRESSORS OF CpG OLIGONUCLEOTIDES |
| 01/12/2012 | US20120009169 Self-forming phospholipidic gels |
| 01/12/2012 | US20120009153 Compositions for bacterial mediated gene silencing and methods of using the same |
| 01/12/2012 | US20120009150 Diaryl ureas for treating virus infections |
| 01/12/2012 | US20120009141 Functionalized pyrrolidines and use thereof as iap inhibitors |
| 01/12/2012 | US20120006716 Humanized anti-il-6 antibodies |
| 01/12/2012 | US20120006323 Nasal devices |
| 01/12/2012 | CA2804648A1 Protein kinase inhibitors and methods of treatment |
| 01/12/2012 | CA2804593A1 Biphenyloxybenzensulphonamide derivatives |
| 01/12/2012 | CA2804511A1 Single-stranded nucleic acid molecule for controlling gene expression |
| 01/12/2012 | CA2804480A1 Macromolecular complex of bacterial origin and use of said macromolecular complex for preventing and treating inflammatory rheumatism |
| 01/12/2012 | CA2804473A1 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate (s1p) receptors |
| 01/12/2012 | CA2804334A1 Xanthenedione derivatives for the treatment of pigmentation and skin ageing disorders |
| 01/12/2012 | CA2804285A1 Bipyridyl derivatives useful for the treatment of kinase - induced diseases |
| 01/12/2012 | CA2804165A1 Piperidinyl pyrimidine amides as kv7 potassium channel openers |
| 01/12/2012 | CA2803090A1 Crystalline form of a 3-phenoxymethylpyrrolidine compound |
| 01/12/2012 | CA2802216A1 Tetrahydrocarboline derivative |
| 01/12/2012 | CA2802132A1 Tetrahydro-pyrido-pyrimidine derivatives |
| 01/11/2012 | EP2404607A1 Boronic acids and esters as inhibitors of fatty acid amide hydrolase |
| 01/11/2012 | EP2404603A1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds for the treatment of CSBP/p38 kinase mediated diseases |
| 01/11/2012 | EP2403854A1 Sulfonylated tetrahydroazolopyrazines and their use as medicinal products |
| 01/11/2012 | EP2403853A1 Pyrrolopyrimidines used as kinase inhibitors |
| 01/11/2012 | EP2403849A1 Oxazole pyridine derivatives useful as s1p1 receptor agonists |
| 01/11/2012 | EP2403846A1 Inhibitors of bruton's tyrosine kinase |
| 01/11/2012 | EP2403539A2 Methods and systems for treatment and/or diagnosis |
| 01/11/2012 | EP2403517A1 Novel antiviral agent |
| 01/11/2012 | EP1994005B9 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents |
| 01/11/2012 | EP1483384B1 Method for overexpression of zwitterionic polysaccharides |
| 01/11/2012 | EP1458687B1 Pyrimidine compounds as interleukin-12 (il-12) inhibitors |
| 01/11/2012 | EP1381377B1 A composition including a ginkgolide and apocynin which interferes with the arachidonic acid cascade |
| 01/11/2012 | CN202105076U Knee protective band |
| 01/11/2012 | CN1767078B Preparation of radium-223, physically accepted preparation and kit |
| 01/11/2012 | CN1642542B Angiogenesis inhibitors |
| 01/11/2012 | CN102317301A Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics |
| 01/11/2012 | CN102317282A Hetero ring derivative |
| 01/11/2012 | CN102317265A 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders |